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http:WHAT THIS PAPER ADDS
Spinal cord ischaemia (SCI) following thoracoabdominal aortic aneurysm (TAAA) repair is a devastating
complication. Reﬁnements in surgical technique and perioperative strategies have reduced the incidence of SCI,
but this phenomenon remains incompletely understood. A prospectively maintained database of patients having
endovascular TAAA repair was reviewed to identify successful strategies for reversing associated neurological
deﬁcits. This paper highlights the importance of a dedicated institutional protocol and adequate critical care
support for facilitating prompt diagnosis and intervention of SCI, thereby reversing most neurological deﬁcits
that occur.Objectives: Spinal cord ischaemia (SCI) following endovascular thoracoabdominal aortic aneurysm (TAAA) repair
is a devastating and unpredictable complication. This study describes a single unit’s experience of SCI in patients
who have had endovascular TAAA repair.
Methods: A prospectively maintained database of patients having endovascular TAAA repair using branched and
fenestrated stent grafts between 2008 and 2014 at a single high volume centre was reviewed. Patients who
developed neurological symptoms and signs related to SCI were identiﬁed and factors associated with onset and
recovery of neurology were analysed.
Results: Sixty-nine patients (median age 73 years, 52 male; Crawford classiﬁcation type I [n ¼ 4], type II [n ¼ 11],
type III [n ¼ 33], type IV [n ¼ 14], type V [n ¼ 7]) underwent endovascular TAAA repair. Twelve patients
developed neurological symptoms/signs related to SCI but this was successfully reversed in eight patients, leaving
four (5.8%) with permanent paraplegia. The median length of aorta covered was not signiﬁcantly different in the
12 patients who developed SCI compared with the cohort that did not. Eleven of the patients who developed SCI
had an intraoperative mean arterial pressure (MAP) below 80 mmHg. Cutaneous atheroemboli were noted in half
of the patients in the SCI group compared with 11% of the non-SCI group (p < .05). Strategies used to reverse SCI
included raising MAP, cerebrospinal ﬂuid drainage, angioplasty of stenosed internal iliac arteries, and restoring
perfusion to the aneurysm sac.
Conclusions: This series highlights some of the risk factors associated with the development of SCI after
endovascular repair of TAAAs. It also illustrates the importance of a dedicated institutional protocol aimed at
ensuring the early diagnosis of SCI and prompt intervention to reverse permanent paraplegia in the majority of
cases.
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Spinal cord ischaemia (SCI) following thoracoabdominal
aortic aneurysm (TAAA) repair is a feared complication that
is associated with a high mortality rate.1 Lower rates of SCI
have been reported for endovascular compared with open
repair, but incidences as high as 30% have been quoted in
contemporary series describing endovascular TAAA
repair.2e4
600 S.H. Rossi et al.SCI after endovascular aneurysm repair can occur from a
combination of reduced spinal cord perfusion as a result of
hypotension, coverage of lumbar and intercostal arteries,
and/or embolisation of atheroma/thrombus into the
aforementioned. A greater understanding of the anatomy
and physiology of spinal cord perfusion has led to recog-
nition of several risk factors associated with SCI after TAAA
repair. These include previous aortic surgery, the length of
aorta covered, loss of collateral blood supply to the spinal
cord via the vertebral and internal iliac arteries, and pro-
longed hypotension.5e12
Reﬁnements in surgical technique and perioperative
strategies have reduced the incidence of SCI,13 but this
phenomenon remains incompletely understood and is not
entirely predictable or preventable. The present study de-
scribes our experience of SCI in patients who have had
endovascular TAAA repair using fenestrated and branched
stent grafts and highlights strategies that have reversed the
consequent neurological deﬁcits in the majority of these
patients.METHODS
A retrospective review of a prospectively maintained data-
base was performed to identify all patients who had an
endovascular TAAA repair using branched or fenestrated
endografts between 2008 and 2014 at St Thomas’ Hospital,
London, UK. Aneurysms were divided according to the
modiﬁed Crawford classiﬁcation system14 based on
anatomical criteria rather than the extent of aortic coverage
required for endovascular TAAA repair. Patients who un-
derwent fenestrated endovascular repair for juxtarenal
aortic aneurysms that could have been repaired at open
surgery using a suprarenal aortic clamp were excluded.
Data were obtained through review of medical records.
Lower limb deﬁcits (motor and/or sensory) were assessed
by a consultant neurologist and classiﬁed as SCI after all
other possible causes (e.g. intracranial pathology,
compartment syndrome, epidural haematoma) had been
excluded. The outcome after SCI was recorded as either
permanent paraplegia or reversible spinal cord ischaemia.
Reversible SCI was further sub-classiﬁed according to
whether the patient had a complete neurological recovery
or partial recovery. Patients in the partial recovery group
had reduced muscle power, based on the Medical Research
Council grading system,15 but were able to walk
independently.
Operative and anaesthetic records were reviewed to
determine the anaesthetic type, duration of the procedure,
intraoperative temperature, heparin administration, and
details regarding spinal drain insertion. Systolic and diastolic
blood pressure was recorded in the perioperative period
using intra-arterial monitoring or non-invasively using a
blood pressure cuff. The lowest recorded mean arterial
pressure (MAP) was calculated based on these readings.
Preoperative and postoperative computed tomography
imaging was analysed to calculate the length of aorta
covered. This was expressed as a percentage of total aorticlength and was measured from the left subclavian artery
(LSA) to the aortic bifurcation. The patencies of the LSA and
internal iliac arteries were also determined.
Age, sex, comorbidities, incidence of prior aortic surgery,
evidence of cutaneous atheroemboli, staged repairs,
amount of aortic coverage, and factors related to periop-
erative blood pressure were compared between the cohort
of patients that developed SCI and those that did not. A
Mann-Whitney U test was used for comparing continuous
data and Fisher’s exact test was used for categorical data.
Operative technique and protective measures against
spinal cord ischaemia
Procedures were carried out either under general or
epidural anaesthesia. Our technique for TAAA repair has
been described elsewhere.16 The LSA is routinely revascu-
larised prior to coverage. The aim is to maintain perfusion
to both internal iliac arteries, using iliac branched devices
where necessary. The activated clotting time (ACT) is
maintained above 200 sec for the duration of surgery by
administration of boluses of intravenous heparin. Large
sheaths are removed and the common femoral arteries are
closed as soon as feasible during the repair to ensure
prompt restoration of perfusion to the internal iliac arteries
and the lower limbs. MAP is targeted above 80 mmHg
intraoperatively and for at least 48 hours after surgery.
Since 2012, procedures for extent II and III TAAAs have been
staged. Strategies used for staging include: (i) placing the
thoracic component prior to deﬁnitive repair; and (ii)
maintaining perfusion to the aneurysm sac by delayed
completion of either one of the stent graft side branches or
the contra-lateral iliac limb extension. Since December 2014
the ﬁnal side branch has been test occluded, and motor
evoked potential monitoring used to assess the effect of
temporary aneurysm sac exclusion on spinal cord perfusion
to determine whether it is necessary to delay completion of
the repair. The current policy is to place a spinal drain prior
to surgery for all Crawford type I, II, III, and V TAAAs and to
begin prophylactic CSF drainage intraoperatively. Passive
drainage of CSF is done at 10 cm H2O until postoperative
day 2, during which time all patients are monitored hourly
for the presence of lower limb neurology. If any signs or
symptoms of spinal cord ischaemia develop, the MAP is
raised to >90e100 mmHg using inotropic support and the
CSF drain initially lowered to 5 cm H2O, maintaining
drainage for up to 5 days. The haemoglobin is maintained at
10 g/dL and kept above 12 g/dL in the presence of lower
limb neurology.
Ethical approval
Ethical approval was not required for this study.
RESULTS
A total of 69 patients underwent an endovascular TAAA
repair between 2008 and 2014 (median age 73 years, 52
male; modiﬁed Crawford classiﬁcation type I [n ¼ 4], type II
[n ¼ 11], type III [n ¼ 33], type IV [n ¼ 14], type V [n ¼ 7]).
Neuroprotective Strategies Can Prevent Permanent Paraplegia 601Twelve (17.3%) patients developed SCI. Of these, ﬁve pa-
tients recovered completely, three patients had a partial
recovery, and four were left permanently paraplegic. The
incidence of permanent paraplegia was 5.8%.Risk factors associated with development of spinal cord
ischaemia
Table 1 demonstrates several factors that were compared
between the cohort of patients in that developed SCI and
those that did not. There was a signiﬁcantly higher rate of
cutaneous atheroembolisation in the SCI group (50% vs.
11%, p < .004). Requirement for postoperative inotropes
(58% vs. 17%, p < 0.006) and incidence of chronic
obstructive pulmonary disease (58% vs. 19%, p < .01) was
also higher in the SCI group. There was no difference in the
length of aorta covered or the number of staged cases in
the two groups.Analysis of characteristics of SCI patients
Table 2 summarises patient demographics, as well as
anatomical factors and operative details for the 12 patients
who developed a lower limb neurological deﬁcit following
TAAA repair (median age 75 years [range 66e87], 10 male).
Of these, ﬁve had previous aortic surgery. One patient had a
LSA stenosis, and ﬁve patients had a stenosis or occlusion of
one internal iliac artery. The median length of aorta covered
was 82% (range 52e100%). Four patients had a staged
repair.
Within the group of 12 patients who developed SCI, two
patients developed symptoms in the immediate post-
operative period, and in the remainder of patients symptomTable 1. Comparative analysis of the cohort of patients who did not d
N
Age, years 7
Sex, M:F 4
Comorbidities, %
CVA 2
CAD 5
COPD 1
DM 2
Prior aortic surgery, % 3
Staged repair, % 2
Length of aorta covered, % 6
Atheroemboli, % 1
Perioperative blood pressure
On preoperative antihypertensives, % 7
Received preoperative antihypertensives, % 5
Preoperative MAP, mmHg 9
Lowest intraoperative MAP, mmHg 6
Intraoperative support required to maintain MAP, % 5
Lowest postoperative MAP, mmHg 7
Received postoperative antihypertensives, % 4
Postoperative support required to maintain MAP, % 1
Date are given as mean (range) or %, unless otherwise stated.
CAD ¼ coronary artery disease; COPD ¼ chronic obstructive pulmonary
F ¼ female; M ¼ male; MAP ¼ mean arterial pressure; SCI ¼ spinalonset was delayed (Table 3). Seven patients had prophy-
lactic spinal drain insertion prior to TAAA repair. All patients
underwent their index TAAA repair under general anaes-
thesia. One patient developed neurological symptoms
following the third stage of their TAAA repair, which
involved percutaneous insertion of the left iliac limb under
local anaesthetic. In the group of patients who developed
SCI, the median duration of surgery was 292 minutes (range
140e475 minutes) and the median dose of heparin
administered intraoperatively was 10,000 units (range
7,500e16,000 units). Cutaneous atheroemboli were noted
postoperatively in half of the patients who developed SCI,
including all patients who developed permanent paraplegia
and in two patients who developed reversible neurological
symptoms.
Ten patients were using antihypertensive medication
preoperatively and in four cases these were not withheld on
the day of surgery (Table 4). Two patients had a MAP
<80 mmHg on the morning of surgery. All but one patient
had a MAP <80 mmHg intraoperatively, and ten patients
required intraoperative pressor agents to maintain blood
pressure. Nine patients had a sustained MAP of <80 mmHg
postoperatively, and seven of these required pressor agents
postoperatively.Details of selected patients who developed spinal cord
ischaemia
Patient 1 had a repair of a type III TAAA and was paraplegic
with a sensory level at T5 after extubation with signs of
widespread atheroembolisation to the lower abdominal
wall and limbs. He died of multi organ failure on the third
postoperative day.evelop spinal cord ischaemia (SCI) with the group that did.
o SCI (n ¼ 57) SCI (n ¼ 12) p
2 (58e84) 75 (66e87) .28
1:16 10:2 .72
1 17 1.0
4 42 .53
9 58 .01
4 0 .11
6 42 .75
0 33 .45
8 (34e100) 82 (52e100) .13
1 50 .004
9 83 1.0
2 40 .73
6 (68e133) 101 (69e119) .61
5 (53e84) 65 (0e90) .79
5 83 .10
1 (0e100) 76 (45e91) .99
6 25 .34
7 58 .006
disease; CVA ¼ cerebrovascular accident; DM ¼ diabetes mellitus;
cord ischaemia.
Table 2. Patient demographics and anatomical characteristics.
Age
(years)
Sex BMI
(kg/m2)
CVA CAD COPD DM Prior aortic
surgery
TAAA
Crawford
classiﬁcation
Aneurysm
diameter
(cm)
Date of
surgery
(month/year)
Graft design Staged
repair
Extent of
aortic
coverage (%)
LSA
patency
IIA patency
Patient 1 77 M 23.4 N Y N N N III 5.9 05/2009 Branches: SMA, both
renals
N 400/450 (88%) Patent Right
embolised,
left patent
Patient 2 72 M 26 Y N Y N Open type IV
TAA repair
III 6.6 03/2011 Branches: coeliac, SMA
and right renal
Fenestration: left renal
N 315/445 (71%) Patent Patent
Patient 3 74 M 23 Y N N N Open infrarenal
AAA repair
III 7.0 11/2011 Branches: coeliac, SMA
and both renals
N 337/551 (61%) Patent Left
occluded
Patient 4 78 M 25.3 N N N N N III 6.0 12/2011 Branch: coeliac and
SMA
Fenestrations: both
renals
N 317/426 (74%) Patent Patent
Patient 5 66 M 37 N N Y N Endovascular
thoracic AA
repair
III 7.2 03/2012 Fenestration: SMA, left
renal, coeliac and right
renal occluded
Y 505/505 (100%) Patent Patent
Patient 6 72 M 27 N Y N N Aortic root
replacement þ
tissue AVR
II 8.5 05/2012 Branches: coeliac,
SMA, both renals
N 552/552 (100%) Carotid to
subclavian
bypass
Left
stenosis
Patient 7 87 M 20 N Y Y N N II 9.0 07/2012 Fenestrations: coeliac,
SMA, both renals
N 391/464 (84%) Patent Patent
Patient 8 75 M 24.7 N Y Y N N IV 6.4 04/2013 Fenestrations: SMA,
both renals, Coeliac
occluded
Y 266/404 (67%) Patent Patent
Patient 9 82 F 30 N Y Y N Endovascular
repair
penetrating
ulcer thoracic
aorta
III 5.6 06/2013 Branch: left renal
Fenestrations: coeliac,
SMA, right renal
N 304/378 (80%) Patent Patent
Patient 10 67 M 25 N N Y N N III 6.2 08/2013 Branches: coeliac, SMA
and both renals
Y 409/471 (86%) Patent Right
stenosis
Patient 11 69 M 23 N N Y N N III 5.8 10/2013 Branches: coeliac, SMA
and both renals
N 213/406 (52%) Stenosis Patent
Patient 12 79 F 25 N N N N N III 7.0 01/2014 Branches: coeliac,
SMA, both renals
Y 480/537 (89%) Patent Left
stenosis
AAA ¼ abdominal aortic aneurysm; AVR ¼ aortic valve replacement; BMI ¼ body mass index; CAD ¼ coronary artery disease; COPD ¼ chronic obstructive pulmonary disease;
CVA ¼ cerebrovascular accident; DM ¼ diabetes mellitus; F ¼ female; IIA ¼ internal iliac artery; LSA ¼ left subclavian artery; M ¼ male; N ¼ no; SMA ¼ superior mesenteric artery;
TAAA ¼ thoracoabdominal aortic aneurysm; Y ¼ yes.
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Table 3. Lower limb neurological symptoms and spinal drainage.
Symptom
onset (hours
postoperatively)
Laterality Neurological deﬁcit Outcome Spinal drain insertion Number of
days spinal
drain
remained
in situ
Patient 1 Immediate Bilateral Motor þ Sensory Permanent paraplegia Prior to induction 3
Patient 2 5 Bilateral Motor Reversible SCI: complete recovery Prior to induction 2
Patient 3 21 Right Motor Reversible SCI: complete recovery Prior to induction 4
Patient 4 Immediate Bilateral Motor þ sensory Permanent paraplegia Prior to induction 4
Patient 5 14 Bilateral Motor þ sensory Permanent paraplegia Prior to induction 3
Patient 6 7 Bilateral Motor þ sensory Permanent paraplegia Prior to induction 3
Patient 7 22 Bilateral Motor Reversible SCI: complete recovery Prior to induction 4
Patient 8 45 Right Motor Reversible SCI: complete recovery After symptom onset 5
Patient 9 17 Right Motor þ sensory Reversible SCI: partial recovery After symptom onset 4
Patient 10 4 Left Motor Reversible SCI: complete recovery After symptom onset 2
Patient 11 22 Bilateral Motor þ sensory Reversible SCI: partial recovery After symptom onset 4
Patient 12 46 Bilateral Motor þ sensory Reversible SCI: partial recovery After symptom onset 4
N ¼ no; Y ¼ yes.
Neuroprotective Strategies Can Prevent Permanent Paraplegia 603Patient 6 had a four branch, single-stage endovascular
TAAA repair and has been the subject of a case report.17
The coeliac artery could not be stented and the decision
was made, therefore, to place an Amplatzer plug to occlude
the coeliac branch. After the patient developed SCI on the
ﬁrst postoperative day, he was returned to the operating
theatre and the coeliac plug was pushed out, restoring
perfusion to the aneurysm sac, with consequent resolution
of the neurological symptoms. A consumptive coagulopathy
developed 12 days later because of ongoing sac perfusion,
necessitating exclusion of the aneurysm once more by re-
insertion of the Amplatzer plug. This resulted in perma-
nent paraplegia.
A two-stage repair was planned for Patient 7, with the
intention to terminate the ﬁrst stage of the repair in the
infra-renal aorta. Hypotension precipitated SCI on day 1
after the ﬁrst stage of repair, but the lower limb neurology
was successfully reversed with elevation of MAP and CSF
drainage. Subsequent CT angiography demonstrated that
the aneurysm sac was sealed as a consequence of the
branched component ending in a narrow portion of infra-
renal aorta with three large lumbar arteries arising from
the uncovered portion of the aorta distal to this compo-
nent. It was decided, therefore, not to extend the repair
into the common iliac arteries, as originally planned for the
second stage of repair, to preserve collateral ﬂow to the
spine by maintaining perfusion to the lumbar arteries. The
patient is on regular surveillance, the aneurysm remains
sealed and has not increased in size.
Patient 9 underwent a single-stage TAAA repair with
fenestrations for the coeliac, SMA and right renal arteries. A
downward facing branch was planned for the left renal
artery. The right renal artery could not be cannulated during
the ﬁrst procedure. A second attempt was made 8 days
later and this time the right renal artery was successfully
stented. Exclusion of the aneurysm sac after placement of
this stent resulted in SCI that was reversed by insertion of a
spinal drain.Patient 10 had a three-stage repair consisting of place-
ment of a proximal thoracic stent graft (ﬁrst stage), followed
by the four-branch component (second stage) a month
later, leaving one iliac limb unstented to maintain perfusion
to the aneurysm sac. One week later the third stage of
repair was completed by insertion of the left iliac limb
percutaneously, under local anaesthetic (Fig. 1). The patient
developed reversible unilateral lower limb weakness 4
hours following the third stage of the repair. Symptoms
were rapidly reversed on spinal CSF drainage and elevation
of MAP.
A two-stage repair with a four-branch device was planned
for Patient 12, with the intention to leave the left iliac limb
extension to be completed 3 weeks after the ﬁrst-stage
repair. The patient developed SCI 2 days after the ﬁrst
stage of the repair, despite leaving the left limb unstented
to maintain perfusion to the aneurysm sac. A right internal
iliac artery stenosis was balloon angioplastied and the pa-
tient made a full recovery (Fig. 2). Neurological symptoms
recurred after placement of the left iliac limb to seal the
aneurysm, but once again resolved following elevation of
MAP and CSF drainage.DISCUSSION
Neurological deﬁcits occurring as a result of SCI after open
or endovascular TAAA repairs can be successfully reversed
in over half of patients.6e8,12 The present case series de-
scribes experience with patients who have developed SCI
after endovascular repair of TAAAs over a 7-year period.
Overall 12 patients had clinical evidence of SCI, but in eight
of these patients the neurological deﬁcit was at least
partially reversed after prompt intervention, which meant
that these patients were walking when discharged from
hospital. The incidence of permanent paraplegia in the
present series was 5.8%. The availability of adequate
infrastructure and a dedicated multidisciplinary team that
allowed prompt diagnosis and expedient instigation of
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604 S.H. Rossi et al.neuroprotective measures are likely to have prevented
permanent damage in most patients who developed SCI.
A collateral network, which receives input from inter-
costal and lumbar segmental vessels, the left subclavian
artery, and the internal iliac arteries, plays an important role
in maintaining spinal perfusion.12,13,18 Not surprisingly,
previous aortic surgery and the length of aortic coverage,
with consequent reduction in spinal perfusion because of
loss of collateral ﬂow, are the factors most commonly
identiﬁed by studies as being associated with SCI.5,6,8,9 A
critical length of aortic coverage of over 50% has been
postulated as a major risk factor.5 The number of segmental
arteries sacriﬁced during TAAA repair is an independent risk
factor for SCI.19 In the present series, the length of aortic
coverage trended higher in the SCI group compared with
the cohort that did not develop SCI (82% vs. 68%) but this
did not reach statistical signiﬁcance, likely because of the
relatively small number of patients and events. A review of
the factors that contributed to the reversal of permanent
paraplegia in individual patients in the series, suggested
that maintenance of perfusion to the collateral network
supplying the spinal cord is a key factor in preventing SCI.
One example is Patient 6 in whom neurological symptoms
recovered once the aneurysm sac was re-perfused, sug-
gesting that the intercostal and lumbar arteries originating
from the aneurysm sac had become critical to the perfusion
of the spinal cord given the coverage of the rest of the
aorta.
Experimental data in animal models show that the
collateral circulation to the spine remodels to compensate
for segmental artery sacriﬁce, suggesting that staging TAAA
repairs may allow development of collaterals and prevent
permanent paraplegia.13,20,21 Extensive (Crawford type II
and III) TAAA repairs have been staged since 2012 and in
the cases of Patient 10 and Patient 12, this strategy may
have been the reason why permanent paraplegia was
avoided. A recent publication from O’Callaghan et al.22
supports this hypothesis, reporting a threefold reduction
in SCI associated with staged repairs, with all neurological
injuries in the staged group being temporary. Kasprzak
et al.23 similarly describe a reduction in the risk of SCI using
temporary aneurysm sac perfusion.
Atheroembolisation of the collateral network is a recog-
nised cause of SCI following thoracoabdominal and
abdominal aneurysm repair.12,22,23 Intravascular manipula-
tion during surgery can precipitate microembolisation from
intra-aortic atheroma and thrombus, with subsequent
segmental infarction of the spinal cord. A signiﬁcant cor-
relation was found between emboli and development of SCI
following endovascular abdominal aortic aneurysm repair in
the EUROSTAR registry.21 Cutaneous embolisation, which
heralds more diffuse embolisation, was noted more
frequently in the patients who developed SCI in the present
series. It was noted in all the patients who develop SCI in
the immediate postoperative period and those left with a
permanent paraplegia.
Understanding of the factors that may be important for
reversing neurological deﬁcits following TAAA repair
Figure 1. Staged repair of type III thoracoabdominal aneurysm. The ﬁrst stage (A) involved placement of the proximal thoracic component,
followed by the four-branch component (second stage) 4 weeks later, leaving one iliac limb unstented (B). The repair was completed 1
week after the second stage by insertion of the left iliac limb (C).
Neuroprotective Strategies Can Prevent Permanent Paraplegia 605remains incomplete. For example, little is known about the
inﬂammatory cascade and the peri-cord oedema that oc-
curs after repair. Established wisdom does suggest, how-
ever, that elevating MAP and spinal CSF drainage are keyFigure 2. Angioplasty of right internal iliac artery stenosis. Suc-
cessful angioplasty of a tight stenosis of the right internal iliac
artery, which may have contributed to resolution of symptoms of
spinal cord ischaemia in patient 12.manoeuvres in attempts to reverse SCI and the present
study supports this. Perioperative hypotension is known to
precipitate SCI following TAAA repair.5,7,24 In the present
series, all but one patient who developed SCI had a MAP
<80 mmHg intraoperatively and all but three patients had a
MAP <80 mmHg in the ﬁrst 24 hours postoperatively. In
two patients, hypotension was identiﬁed as a clear precip-
itant for neurological symptoms, which resolved on nor-
malisation of blood pressure. Others have also related a
period of haemodynamic instability to the development of
delayed symptoms of SCI.10,12 Duration of surgery and
perioperative blood loss are also recognised risk factors for
SCI.5,10 This highlights the need for careful perioperative
blood pressure monitoring, maintaining a relatively high
MAP post TAAA repair and close monitoring in intensive
care facilities to allow rapid recognition of hypotension and
use of inotropes to correct this. Maurel et al.,4 for example,
have demonstrated a signiﬁcant reduction in the rate of SCI
following the introduction of an aggressive perioperative
management protocol. This included early pelvic and lower
limb reperfusion, aggressive blood and platelet transfusion,
maintenance of MAP >85 mmHg, and systematic CSF
drainage.
CSF drainage augments spinal cord perfusion by
decreasing the intrathecal pressure and has been shown to
reduce the incidence of SCI,23 but there remains a lack of
consensus regarding routine prophylactic insertion of spinal
drains.25 Cognisant of the risks associated with CSF
drainage, including intraspinal/subdural haematoma
606 S.H. Rossi et al.formation, infection, CSF ﬁstula formation, and catheter
retention, the authors, in line with other centres, now
consider prophylactic drainage to be an essential adjunct
for the more extensive TAAA repairs.2e4,26,27 In the present
series, prompt CSF drainage was associated with recovery of
neurological symptoms, albeit that CSF was drained and
MAP raised simultaneously, making it difﬁcult to tease out
the relative contribution of each intervention. Intrathecal
papaverine, intraoperative permissive hypothermia, and
epidural cooling are other methods suggested for
decreasing spinal cord metabolic demands and therefore
SCI, but more studies are required to demonstrate a clear
value for using these strategies.10,12,28
The present study is limited by the relatively small
number of SCI events in a retrospective observational case
series. Therefore, claims of strong associations between SCI
and potential risk factors are precluded. Evaluation of
neurological deﬁcit was based on documentation in patient
records and symptoms and signs were not scored according
to recognised systems.6,8 Studying factors associated with
SCI after endovascular TAAA repair is challenging because
the procedure is carried out in a few specialist centres. The
authors advocate an initiative to systematically collate the
experience from these centres in an effort to reﬁne stra-
tegies against SCI.
CONCLUSION
Experience of spinal cord ischaemia is described in patients
who have had endovascular TAAA repair using fenestrated
and branched devices over a 7-year period. This series
highlights the importance of a dedicated institutional pro-
tocol and adequate critical care support for facilitating
prompt diagnosis and intervention, thereby reversing most
neurological deﬁcits that occur. Understanding of the mul-
tiple mechanisms that govern SCI after endovascular TAAA
repair remains incomplete, however, and merits research
using a collaborative approach between high volume
centres.
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